Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Response to commentary by Lu and Wang on "Salivary biomarkers for cancer diagnosis: a meta-analysis".

Rapado-González Ó, Martínez-Reglero C, Salgado-Barreira Á, Takkouche B, López-López R, Suárez-Cunqueiro MM, Muinelo-Romay L.

Ann Med. 2020 Apr 2:1. doi: 10.1080/07853890.2020.1746391. [Epub ahead of print] No abstract available.

PMID:
32202950
2.

EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Gazzaniga P, Groen HJM, Krebs MG, Muinelo-Romay L, Pantel K, Rossi E, Terstappen L, Wikman H, Soria JC, Farace FF, Renehan A, Dive C, Besse B, Michiels S.

Ann Oncol. 2019 Apr;30 Suppl 2:ii7. doi: 10.1093/annonc/mdz073. No abstract available.

3.

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.

Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R.

Cells. 2020 Feb 24;9(2). pii: E522. doi: 10.3390/cells9020522.

4.

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer.

Casas-Arozamena C, Díaz E, Moiola CP, Alonso-Alconada L, Ferreirós A, Abalo A, Gil CL, Oltra SS, de Santiago J, Cabrera S, Sampayo V, Bouso M, Arias E, Cueva J, Colas E, Vilar A, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L.

J Clin Med. 2020 Feb 21;9(2). pii: E585. doi: 10.3390/jcm9020585.

5.

Salivary biomarkers for cancer diagnosis: a meta-analysis.

Rapado-González Ó, Martínez-Reglero C, Salgado-Barreira Á, Takkouche B, López-López R, Suárez-Cunqueiro MM, Muinelo-Romay L.

Ann Med. 2020 Feb 14:1-20. doi: 10.1080/07853890.2020.1730431. [Epub ahead of print]

PMID:
32056455
6.

Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells.

Abreu M, Cabezas-Sainz P, Pereira-Veiga T, Falo C, Abalo A, Morilla I, Curiel T, Cueva J, Rodríguez C, Varela-Pose V, Lago-Lestón R, Mondelo P, Palacios P, Moreno-Bueno G, Cano A, García-Caballero T, Pujana MÁ, Sánchez-Piñón L, Costa C, López R, Muinelo-Romay L.

J Clin Med. 2020 Jan 27;9(2). pii: E353. doi: 10.3390/jcm9020353.

7.

Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.

Rapado-González Ó, López-López R, López-Cedrún JL, Triana-Martínez G, Muinelo-Romay L, Suárez-Cunqueiro MM.

Cells. 2019 Dec 17;8(12). pii: E1653. doi: 10.3390/cells8121653. Review.

8.

Extracellular Vesicles-Based Biomarkers Represent a Promising Liquid Biopsy in Endometrial Cancer.

Herrero C, de la Fuente A, Casas-Arozamena C, Sebastian V, Prieto M, Arruebo M, Abalo A, Colás E, Moreno-Bueno G, Gil-Moreno A, Vilar A, Cueva J, Abal M, Muinelo-Romay L.

Cancers (Basel). 2019 Dec 12;11(12). pii: E2000. doi: 10.3390/cancers11122000.

9.

CTCs Expression Profiling for Advanced Breast Cancer Monitoring.

Pereira-Veiga T, Martínez-Fernández M, Abuin C, Piñeiro R, Cebey V, Cueva J, Palacios P, Blanco C, Muinelo-Romay L, Abalo A, Costa C, López-López R.

Cancers (Basel). 2019 Dec 4;11(12). pii: E1941. doi: 10.3390/cancers11121941.

10.

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.

Rapado-González Ó, Majem B, Álvarez-Castro A, Díaz-Peña R, Abalo A, Suárez-Cabrera L, Gil-Moreno A, Santamaría A, López-López R, Muinelo-Romay L, Suarez-Cunqueiro MM.

J Clin Med. 2019 Nov 20;8(12). pii: E2029. doi: 10.3390/jcm8122029.

11.

miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis.

Rapado-González O, Martínez-Reglero C, Salgado-Barreira A, López-López R, Suárez-Cunqueiro MM, Muinelo-Romay L.

Oral Oncol. 2019 Dec;99:104465. doi: 10.1016/j.oraloncology.2019.104465. Epub 2019 Nov 20. Review.

PMID:
31756680
12.

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer.

Picardo F, Romanelli A, Muinelo-Romay L, Mazza T, Fusilli C, Parrella P, Barbazán J, Lopez-López R, Barbano R, De Robertis M, Taffon C, Bordoni V, Agrati C, Costantini M, Ricci F, Graziano P, Maiello E, Muscarella LA, Fazio VM, Poeta ML.

Cancers (Basel). 2019 Oct 19;11(10). pii: E1598. doi: 10.3390/cancers11101598.

13.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Lindsay CR, Blackhall FH, Carmel A, Fernandez-Gutierrez F, Gazzaniga P, Groen HJM, Hiltermann TJN, Krebs MG, Loges S, López-López R, Muinelo-Romay L, Pantel K, Priest L, Riethdorf S, Rossi E, Terstappen L, Wikman H, Soria JC, Farace F, Renehan A, Dive C, Besse B, Michiels S.

Eur J Cancer. 2019 Aug;117:60-68. doi: 10.1016/j.ejca.2019.04.019. Epub 2019 Jun 27.

14.

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.

Rapado-González Ó, Álvarez-Castro A, López-López R, Iglesias-Canle J, Suárez-Cunqueiro MM, Muinelo-Romay L.

Cancers (Basel). 2019 Jun 27;11(7). pii: E898. doi: 10.3390/cancers11070898. Review.

15.

Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients.

Ribeiro-Samy S, Oliveira MI, Pereira-Veiga T, Muinelo-Romay L, Carvalho S, Gaspar J, Freitas PP, López-López R, Costa C, Diéguez L.

Sci Rep. 2019 May 29;9(1):8032. doi: 10.1038/s41598-019-44401-1.

16.

Lung Cancer and Liquid Biopsy: Realities and Challenges in Routine Clinical Practice.

Muinelo-Romay L, García-González J, León-Mateos L.

Arch Bronconeumol. 2019 Jun;55(6):289-290. doi: 10.1016/j.arbres.2018.11.011. Epub 2019 Jan 11. English, Spanish. No abstract available.

PMID:
30639091
17.

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.

García-Foncillas J, Tabernero J, Élez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, López R, Muinelo-Romay L, Montagut C, Antón A, López G, Díaz-Rubio E, Rojo F, Vivancos A.

Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

18.

CTCs-derived xenograft development in a triple negative breast cancer case.

Pereira-Veiga T, Abreu M, Robledo D, Matias-Guiu X, Santacana M, Sánchez L, Cueva J, Palacios P, Abdulkader I, López-López R, Muinelo-Romay L, Costa C.

Int J Cancer. 2019 May 1;144(9):2254-2265. doi: 10.1002/ijc.32001. Epub 2018 Dec 16.

PMID:
30450632
19.

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.

Muinelo-Romay L, Casas-Arozamena C, Abal M.

Int J Mol Sci. 2018 Aug 7;19(8). pii: E2311. doi: 10.3390/ijms19082311. Review.

20.

Liquid Biopsy in Oral Cancer.

Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun JL, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro MM.

Int J Mol Sci. 2018 Jun 8;19(6). pii: E1704. doi: 10.3390/ijms19061704. Review.

21.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K.

J Natl Cancer Inst. 2018 Jun 1;110(6):560-567. doi: 10.1093/jnci/djy018.

PMID:
29659933
22.

Human salivary microRNAs in Cancer.

Rapado-González Ó, Majem B, Muinelo-Romay L, Álvarez-Castro A, Santamaría A, Gil-Moreno A, López-López R, Suárez-Cunqueiro MM.

J Cancer. 2018 Jan 6;9(4):638-649. doi: 10.7150/jca.21180. eCollection 2018. Review.

23.

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination.

Figueras A, Alsina-Sanchís E, Lahiguera Á, Abreu M, Muinelo-Romay L, Moreno-Bueno G, Casanovas O, Graupera M, Matias-Guiu X, Vidal A, Villanueva A, Viñals F.

Mol Cancer Ther. 2018 Feb;17(2):532-543. doi: 10.1158/1535-7163.MCT-17-0643. Epub 2017 Nov 16.

24.

Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.

Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D.

Eur J Cancer. 2017 Dec;87:30-37. doi: 10.1016/j.ejca.2017.09.028. Epub 2017 Nov 2.

PMID:
29102858
25.

Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients.

León-Mateos L, Casas H, Abalo A, Vieito M, Abreu M, Anido U, Gómez-Tato A, López R, Abal M, Muinelo-Romay L.

Oncotarget. 2017 May 19;8(33):54708-54721. doi: 10.18632/oncotarget.18025. eCollection 2017 Aug 15.

26.

Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.

Salvador F, Martin A, López-Menéndez C, Moreno-Bueno G, Santos V, Vázquez-Naharro A, Santamaria PG, Morales S, Dubus PR, Muinelo-Romay L, López-López R, Tung JC, Weaver VM, Portillo F, Cano A.

Cancer Res. 2017 Nov 1;77(21):5846-5859. doi: 10.1158/0008-5472.CAN-16-3152. Epub 2017 Jul 18.

27.

Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study.

Insua YV, Cámara J, Vázquez EB, Fernández A, Rivera FV, Silva MJVV, Barbazán J, Muinelo-Romay L, Folgar SC, Abalo A, López-López R, Abal M, Alonso-Alconada L.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1265. doi: 10.3390/ijms18061265.

28.

Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer.

Mariscal J, Alonso-Nocelo M, Muinelo-Romay L, Barbazan J, Vieito M, Abalo A, Gomez-Tato A, Maria de Los Angeles CC, Garcia-Caballero T, Rodriguez C, Brozos E, Baron F, Lopez-Lopez R, Abal M.

Sci Rep. 2016 Nov 30;6:37820. doi: 10.1038/srep37820.

29.

EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.

Vila A, Abal M, Muinelo-Romay L, Rodriguez-Abreu C, Rivas J, López-López R, Costa C.

PLoS One. 2016 Oct 6;11(10):e0163705. doi: 10.1371/journal.pone.0163705. eCollection 2016.

30.

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.

León-Mateos L, Vieito M, Anido U, López López R, Muinelo Romay L.

Int J Mol Sci. 2016 Sep 20;17(9). pii: E1580. Review.

31.

Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity.

Rapado-González Ó, Majem B, Muinelo-Romay L, López-López R, Suarez-Cunqueiro MM.

Int J Mol Sci. 2016 Sep 12;17(9). pii: E1531. doi: 10.3390/ijms17091531. Review.

32.

Detection of circulating melanoma cells in choroidal melanocytic lesions.

Bande MF, Santiago M, Muinelo-Romay L, Blanco MJ, Mera P, Capeans C, Pardo M, Piñeiro A.

BMC Res Notes. 2015 Sep 17;8:452. doi: 10.1186/s13104-015-1420-5.

33.

Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Pedrola N, Devis L, Llauradó M, Campoy I, Martinez-Garcia E, Garcia M, Muinelo-Romay L, Alonso-Alconada L, Abal M, Alameda F, Mancebo G, Carreras R, Castellví J, Cabrera S, Gil-Moreno A, Matias-Guiu X, Iovanna JL, Colas E, Reventós J, Ruiz A.

Clin Exp Metastasis. 2015 Jun;32(5):467-78. doi: 10.1007/s10585-015-9720-7. Epub 2015 Apr 30.

PMID:
25924802
34.

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.

Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J, Wik E, Hapangama D, Coenegrachts L, Cano A, Gil-Moreno A, Chiva L, Cueva J, Vieito M, Ortega E, Mariscal J, Colas E, Castellvi J, Cusido M, Dolcet X, Nijman HW, Bosse T, Green JA, Romano A, Reventos J, Lopez-Lopez R, Salvesen HB, Amant F, Matias-Guiu X, Moreno-Bueno G, Abal M; ENITEC Consortium.

Mol Cancer. 2014 Sep 27;13:223. doi: 10.1186/1476-4598-13-223.

35.

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.

Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M.

Carcinogenesis. 2014 Dec;35(12):2679-86. doi: 10.1093/carcin/bgu198. Epub 2014 Sep 18.

PMID:
25233929
36.

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

Alonso-Alconada L, Santacana M, Garcia-Sanz P, Muinelo-Romay L, Colas E, Mirantes C, Monge M, Cueva J, Oliva E, Soslow RA, Lopez MA, Palacios J, Prat J, Valls J, Krakstad C, Salvesen H, Gil-Moreno A, Lopez-Lopez R, Dolcet X, Moreno-Bueno G, Reventos J, Matias-Guiu X, Abal M.

Int J Cancer. 2015 Apr 15;136(8):1863-73. doi: 10.1002/ijc.29213. Epub 2014 Sep 29.

37.

A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.

Barbazán J, Muinelo-Romay L, Vieito M, Candamio S, Díaz-López A, Cano A, Gómez-Tato A, Casares de Cal Mde L, Abal M, López-López R.

Int J Cancer. 2014 Dec 1;135(11):2633-43. doi: 10.1002/ijc.28910. Epub 2014 Apr 29.

38.

Biosensors for the detection of circulating tumour cells.

Costa C, Abal M, López-López R, Muinelo-Romay L.

Sensors (Basel). 2014 Mar 10;14(3):4856-75. doi: 10.3390/s140304856. Review.

39.

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.

Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, López RL.

Cancers (Basel). 2014 Jan 21;6(1):153-65. doi: 10.3390/cancers6010153.

40.

Zoledronic acid as an antimetastatic agent for different human tumor cell lines.

Muinelo-Romay L, Garcia D, Alonso-Alconada L, Vieito M, Carmona M, Martínez N, Aguín S, Abal M, López-López R.

Anticancer Res. 2013 Dec;33(12):5295-300.

PMID:
24324062
41.

FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer.

Villar-Portela S, Muinelo-Romay L, Cuevas E, Gil-Martín E, Fernández-Briera A.

Histopathology. 2013 Aug;63(2):174-86. doi: 10.1111/his.12157. Epub 2013 Jun 3.

PMID:
23730929
42.

Molecular characterization of circulating tumor cells in human metastatic colorectal cancer.

Barbazán J, Alonso-Alconada L, Muinelo-Romay L, Vieito M, Abalo A, Alonso-Nocelo M, Candamio S, Gallardo E, Fernández B, Abdulkader I, de Los Ángeles Casares M, Gómez-Tato A, López-López R, Abal M.

PLoS One. 2012;7(7):e40476. doi: 10.1371/journal.pone.0040476. Epub 2012 Jul 10.

43.

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.

Barbazán J, Vieito M, Abalo A, Alonso-Alconada L, Muinelo-Romay L, Alonso-Nocelo M, León L, Candamio S, Gallardo E, Anido U, Doll A, de los Ángeles Casares M, Gómez-Tato A, Abal M, López-López R.

J Cell Mol Med. 2012 Oct;16(10):2342-9. doi: 10.1111/j.1582-4934.2012.01544.x.

44.

Tumor invasion and oxidative stress: biomarkers and therapeutic strategies.

Muinelo-Romay L, Alonso-Alconada L, Alonso-Nocelo M, Barbazan J, Abal M.

Curr Mol Med. 2012 Jul 1;12(6):746-62. Review.

PMID:
22292441
45.

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

Colas E, Muinelo-Romay L, Alonso-Alconada L, Llaurado M, Monge M, Barbazan J, Gonzalez M, Schoumacher M, Pedrola N, Ertekin T, Devis L, Ruiz A, Castellvi J, Doll A, Gil-Moreno A, Vazquez-Levin M, Lapyckyj L, Lopez-Lopez R, Robine S, Friederich E, Castro M, Reventos J, Vignjevic D, Abal M.

Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.

PMID:
22266854
46.

Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer.

Muinelo-Romay L, Villar-Portela S, Cuevas E, Gil-Martín E, Fernández-Briera A.

BMC Cancer. 2011 Dec 7;11:508. doi: 10.1186/1471-2407-11-508.

47.

Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression.

Villar-Portela S, Muinelo-Romay L, Cuevas E, Gil-Martín E, Fernández-Briera A.

Pathobiology. 2011;78(4):201-9. doi: 10.1159/000326768. Epub 2011 Jul 19.

48.

α(1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma.

Muinelo-Romay L, Villar-Portela S, Cuevas Alvarez E, Gil-Martín E, Fernández-Briera A.

Hum Pathol. 2011 Nov;42(11):1740-50. doi: 10.1016/j.humpath.2011.01.021. Epub 2011 Jun 8.

PMID:
21652057
49.

High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion.

Muinelo-Romay L, Colas E, Barbazan J, Alonso-Alconada L, Alonso-Nocelo M, Bouso M, Curiel T, Cueva J, Anido U, Forteza J, Gil-Moreno A, Reventos J, Lopez-Lopez R, Abal M.

Mol Cancer Ther. 2011 Aug;10(8):1357-66. doi: 10.1158/1535-7163.MCT-10-1019. Epub 2011 May 25.

50.

α(1,2)fucosylation in human colorectal carcinoma.

Muinelo-Romay L, Gil-Martín E, Fernández-Briera A.

Oncol Lett. 2010 Mar;1(2):361-366. Epub 2010 Mar 1.

Supplemental Content

Loading ...
Support Center